Paraquat Lawsuit [September 2026 Update] | Parkinson's Claims

The Paraquat MDL added just 1 case between August and September, increasing from 6,665 to 6,666.

The nearly flat docket comes as the litigation remains focused on the ongoing Syngenta settlement process, including the handling of plaintiffs who have opted out and are continuing to pursue their claims.

Outside the courtroom, the Paraquat Prevention Act introduced in Congress in June would ban the herbicide nationwide by canceling its federal registrations.

With more than 6,600 cases pending, new filing activity has largely stalled compared with earlier stages of the Paraquat litigation.

California pesticide regulators began formally phasing out paraquat-dichloride as of August 10, after every manufacturer selling the herbicide in the state voluntarily withdrew their product registrations.

The move follows Syngenta’s March announcement that it would stop manufacturing paraquat altogether, ending a state review process that began in November 2024 after preliminary studies identified potential links between paraquat exposure and thyroid impacts and birth defects.

The phase-out closes out a state reevaluation triggered by a 2024 California law that had originally sought to sunset paraquat outright, before being revised to instead require a formal state review by January 2029.

Advocates say the shift comes too late for many affected communities, and have raised concerns that manufacturers may still avoid having to publicly disclose health and safety data that would have been required under the original bill.

Syngenta continues to deny any link between paraquat and Parkinson’s disease, even as it faces thousands of pending lawsuits nationwide alleging the company concealed that risk from farmworkers.

Licensed dealers can continue selling existing paraquat stock in California for up to two years, meaning the chemical won’t disappear from the market immediately even as its long-term use in the state comes to an end.

Almond growers in Stanislaus, Kern, Merced, Butte, and Fresno counties, among the heaviest users of the herbicide statewide, are expected to feel the impact most directly as they search for alternative weed-management tools.

A Mississippi man has sued Syngenta Crop Protection and Chevron U.S.A., alleging the herbicide paraquat caused his Parkinson’s disease. He filed the complaint July 28 in the Southern District of Illinois. 

He worked on a farm from 1963 to 1971, where he was repeatedly exposed to the herbicide. 

He wasn’t diagnosed with Parkinson’s until October 2024. 

He alleges he was never given safety equipment or warned about the risks. 

Paraquat was first introduced under the brand name Gramoxone in 1964. 

His suit is one of nearly 6,700 Paraquat cases pending in the federal MDL. 

The complaint cites studies linking paraquat to oxidative stress and dopaminergic neuron damage. 

It also cites a two- to five-fold increased Parkinson’s risk in exposed populations. 

The suit raises claims of design defect, failure to warn, and negligence. 

It also alleges violations of the Mississippi Consumer Protection Act. 

He is seeking both compensatory and punitive damages.

The filing comes as both sides work to finalize a settlement first announced in April 2025. 

That agreement has paused the litigation before Judge Nancy Rosenstengel. 

If the deal falls through, the court is expected to resume bellwether trials. 

Syngenta announced a global phaseout of paraquat production this past June. 

The company still denies any link between the herbicide and Parkinson’s disease.

The Pennsylvania House Consumer Protection, Technology and Utilities Committee has unanimously advanced House Bill 1135, legislation that would ban the use of paraquat throughout the state.

The bill, introduced by State Representative Natalie Mihalek, now moves to the full General Assembly.

If approved by both chambers, it will head to Governor Josh Shapiro for consideration.

The proposed ban comes as paraquat remains the subject of thousands of lawsuits alleging exposure to the herbicide caused Parkinson’s disease.

While the EPA continues to allow restricted agricultural use of paraquat in the United States, more than 70 countries have banned the chemical.

If Pennsylvania ultimately enacts HB 1135, it would become one of the latest states to take legislative action as litigation and scientific research surrounding paraquat continue to grow.

Philadelphia Court of Common Pleas Judge Joshua Roberts is standing by his decision to keep several Paraquat Parkinson’s disease lawsuits in Philadelphia and has recommended that the Pennsylvania Superior Court uphold his ruling.

Syngenta and Chevron are appealing the judge’s denial of their request to move nine bellwether cases to other jurisdictions.

Judge Roberts said the companies failed to provide sufficient reasons to override the plaintiffs’ choice of forum or show that keeping the cases in Philadelphia would create significant difficulty or expense.

The judge also cited the efficiency of coordinating nearly 2,000 Paraquat cases through Philadelphia’s Complex Litigation Center, where centralized discovery, pretrial rulings, and bellwether trials can support the broader litigation.

Another bellwether trial is scheduled for this fall after the first planned trial settled earlier this year.

U.S. District Judge Nancy Rosenstengel has ordered Paraquat lawsuit plaintiffs who reject Syngenta’s settlement terms to meet with a special master by mid-July to confirm that they are making an informed decision.

The court also requires selected plaintiffs who opt out to undergo depositions by early August and participate in limited third-party discovery concerning their paraquat use.

The orders come as the court examines high opt-out rates among clients represented by several law firms.

In one example cited by the judge, 183 of 217 Paraquat plaintiffs represented by a single law firm opted out of the settlement.

The court has selected some plaintiffs from these firms for additional case review while the broader settlement process continues.

The Paraquat MDL added 14 cases between June and July, increasing from 6,651 to 6,665.

The litigation continued to draw legislative attention in June after members of Congress introduced the Paraquat Prevention Act, a bipartisan bill that would ban the herbicide nationwide because of concerns over its alleged link to Parkinson’s disease.

While the proposed legislation would not directly affect the MDL, it reflects growing scrutiny of Paraquat as thousands of lawsuits continue to move through the federal court system.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat lawsuit instantly.

A recent U.S. Supreme Court decision in Monsanto v. Durnell could have broader implications for pesticide lawsuits, by limiting certain state-law failure-to-warn claims involving EPA-approved pesticide labels.

The Court ruled that federal law may preempt failure-to-warn lawsuits when the Environmental Protection Agency has determined a specific warning is not required and the manufacturer cannot add the warning without EPA approval.

The decision arose from Roundup cancer litigation, but attorneys are closely watching whether defendants in other pesticide lawsuits attempt to rely on the ruling in future court filings.

Paraquat manufacturers have consistently argued that federal pesticide regulations preempt state-law warning claims, while plaintiffs contend manufacturers knew or should have known about links between paraquat exposure and Parkinson’s disease and should have provided stronger warnings.

Although the Supreme Court’s ruling does not directly decide the merits of the Paraquat lawsuit, it could become an important issue in ongoing litigation as courts determine whether the decision applies more broadly.

A bipartisan group of federal lawmakers has introduced legislation to ban paraquat nationwide as thousands of Parkinson’s disease lawsuits continue and settlement negotiations progress.

The Paraquat Prevention Act would cancel all current registrations for paraquat products, prohibit future registrations, ban the sale and use of existing supplies, and establish a zero-tolerance standard for paraquat residue in food.

The proposal comes as paraquat manufacturers continue working toward a potential global settlement to resolve nearly 6,700 lawsuits alleging that long-term exposure to the herbicide caused Parkinson’s disease.

Although the legislation’s future remains uncertain, it adds to growing pressure on paraquat manufacturers following Syngenta’s announcement that it plans to phase out global production of the herbicide, and as more states consider restrictions similar to Vermont’s statewide ban.

The judge overseeing the federal Paraquat MDL has ordered plaintiffs’ settlement administrators to provide detailed information about claimants who may reject or remain undecided about a proposed settlement program.

A court-appointed Special Master will review the information as part of the ongoing settlement process.

The Special Master has been tasked with helping claimants evaluate their options before making final decisions about participation.

According to the order, settlement administrators must identify three groups of plaintiffs.

These include individuals deemed ineligible for the settlement, those who have opted out or indicated they plan to opt out, and those who have not yet decided whether to participate.

The court also established deadlines for providing the information.

The disclosures are expected to help the Special Master communicate directly with affected claimants and address questions about the settlement process.

The order comes as attorneys continue efforts to secure broader participation in a proposed resolution of the litigation.

Thousands of Paraquat lawsuits alleging a link between the herbicide and Parkinson’s disease remain pending in the MDL.

By involving a Special Master, the court appears focused on addressing concerns from claimants who remain outside the settlement program.

The process may also help identify issues that could delay implementation of any final agreement and provide additional information to plaintiffs who have not yet made a decision.

Plaintiffs in the Philadelphia paraquat litigation have asked the court to reject renewed efforts by Syngenta and Chevron to move a group of Parkinson’s disease lawsuits out of the city’s mass tort program.

According to a recent filing, the plaintiffs argue that the court already rejected a similar request in 2025 and that the defendants are again seeking to transfer cases that are approaching trial.

The dispute involves 14 cases currently pending in the Philadelphia Court of Common Pleas.

Plaintiffs contend that transferring the lawsuits now would force them to restart litigation in other jurisdictions after years of case development and discovery.

They also argue that moving the cases could delay resolution by placing them behind thousands of pending claims in the federal Paraquat MDL.

The filing comes as the litigation continues to move toward trial. While the first scheduled bellwether case settled before trial, another case remains set for trial in August.

Plaintiffs maintain that the Philadelphia court has already invested substantial resources in preparing these cases for trial and that transferring them at this stage would create unnecessary delays.

The judge overseeing the federal Paraquat multidistrict litigation has ordered limited discovery in a group of cases after identifying unusually high settlement opt out rates among clients represented by several law firms.

Chief Judge Nancy Rosenstengel of the Southern District of Illinois said the court wants to better understand why large numbers of eligible plaintiffs declined settlement offers.

According to court orders issued in early June, the judge selected approximately 10% of opt out cases from several firms for limited discovery.

The selected cases will undergo completion of Plaintiff Fact Sheets, plaintiff depositions, and limited third party discovery where necessary.

The court stated that more than 90% of eligible clients represented by two firms opted out of settlement offers, while more than 80% of eligible clients represented by another firm also declined participation.

Judge Rosenstengel explained that the discovery process is intended to provide the court with a better understanding of the reasons behind the high number of opt outs.

The orders indicate that third party discovery may include efforts to verify evidence of paraquat use or applicator licensing when supporting documentation is unavailable.

The Paraquat MDL has been pending in the Southern District of Illinois since 2021 and involves claims alleging that exposure to the herbicide paraquat caused Parkinson’s disease.

Settlement efforts have remained a central focus of the litigation in recent months as the parties work through the resolution process.

Syngenta has filed a motion seeking to challenge Philadelphia’s Complex Litigation Center as the venue for lawsuits alleging that exposure to paraquat caused Parkinson’s disease.

The motion was filed under seal and seeks to move the litigation from the Philadelphia mass tort program.

The lawsuits were brought by individuals who allege they developed Parkinson’s disease after exposure to paraquat.

Plaintiffs claim Syngenta, Chevron, and FMC Corp. failed to adequately disclose the risks associated with the herbicide.

The companies deny the allegations.

The venue challenge follows earlier efforts by Syngenta and Chevron to move the cases out of Philadelphia.

Those requests were previously denied, with the court finding that the Complex Litigation Center was capable of handling the litigation.

According to court filings, more than 1,600 cases were pending in the Philadelphia proceedings as of January. A bellwether trial that had been scheduled earlier this year resolved before trial.

Separate paraquat litigation also remains pending in federal multidistrict litigation proceedings in Illinois.

The Paraquat MDL added 71 cases between May and June, increasing from 6,580 to 6,651.

The continued growth comes as concerns over Paraquat’s alleged link to Parkinson’s disease gained additional attention in May, when Illinois lawmakers introduced legislation that would ban the herbicide statewide.

While the proposed ban would not affect the federal litigation directly, it reflects growing scrutiny of Paraquat’s safety and ongoing debate over the risks associated with long-term exposure.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat lawsuit instantly.

Illinois lawmakers are facing renewed pressure to ban paraquat as advocates and the Michael J. Fox Foundation push legislation linking the herbicide to Parkinson’s disease and neurological damage.

Senate Bill 3161 would prohibit the use of paraquat in Illinois beginning January 1, 2027, while still allowing limited research exemptions under strict oversight.

Supporters argue the proposal reflects mounting scientific evidence connecting paraquat exposure to Parkinson’s disease, particularly among agricultural workers and individuals living near treated fields.

Advocates pointed to studies suggesting people who handle paraquat may be more than twice as likely to develop Parkinson’s disease.

Lawmakers supporting the measure also noted that paraquat is frequently used in laboratory settings to intentionally replicate Parkinson’s-like symptoms during neurological research.

The legislative push comes as thousands of paraquat lawsuits continue moving through courts nationwide.

Plaintiffs allege manufacturers failed to adequately warn users about the herbicide’s neurological risks despite decades of research examining potential links to Parkinson’s disease.

Opponents of the Illinois proposal argue the science remains disputed and note that paraquat continues to be approved for use in the United States despite bans in more than 70 countries, including throughout the European Union.

While the bill currently remains stalled in committee, the debate reflects growing political and regulatory scrutiny surrounding paraquat as litigation and public pressure continue to expand nationwide.

The Paraquat MDL added 38 cases between April and May, increasing from 6,542 to 6,580 cases pending.

Multiple states are attempting to ban or limit the use of Paraquat across the country, putting additional pressure on pesticide manufacturers outside of the mass tort litigation.

Syngenta also announced that it will cease production of Paraquat by June of this year, claiming they are “shifting to new technologies”.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat lawsuit instantly.

Former EPA officials and public health advocates are urging the federal government to ban paraquat, a widely used weed killer, citing growing scientific evidence linking the chemical to Parkinson’s disease.

The push reflects increasing concern that continued use exposes workers and nearby communities to a neurotoxic substance associated with long-term neurological harm.

Paraquat has been the subject of extensive research and regulatory debate, with studies indicating that chronic exposure can significantly increase the risk of developing Parkinson’s disease.

Despite these concerns, the herbicide remains in use in the United States, even as dozens of countries have banned it due to safety risks.

This regulatory pressure directly mirrors the core issues in ongoing paraquat litigation, where thousands of plaintiffs allege the chemical caused their Parkinson’s disease.

Central to those cases is the question of causation, specifically whether exposure to paraquat can be shown to substantially contribute to the development of the condition.

The calls for a ban also reinforce claims that manufacturers failed to adequately warn users about the risks and continued to market the product despite mounting evidence of harm.

These issues, including scientific causation, failure to warn, and product safety, remain the primary focus of the litigation as courts evaluate liability.

A federal judge overseeing the Paraquat multidistrict litigation has ordered both parties to submit detailed information regarding proposed settlement offers to a court-appointed Special Master.

The directive requires disclosure by April 20, 2026, and is intended to facilitate review of the settlement framework and ensure plaintiffs understand their legal options before making decisions.

U.S. District Judge Nancy Rosenstengel issued the order as part of ongoing efforts to manage thousands of claims alleging that exposure to the herbicide Paraquat caused Parkinson’s disease.

The Special Master will evaluate the terms of the proposed settlement and may meet with plaintiffs and their counsel, particularly those who have not agreed to resolve their claims.

The review process is designed to confirm that claimants are adequately informed about the structure and implications of any potential resolution.

Following the review, the Special Master is required to provide a report to the court within ninety days.

The report may include recommendations or observations regarding the fairness and administration of the proposed settlement.

The order does not finalize any settlement and no compensation amounts have been publicly confirmed.

The litigation remains ongoing as the court continues to oversee negotiations and evaluate whether a global resolution can be achieved.

The Paraquat litigation added 33 cases between March and April, increasing from 6,542 to 6,509.

Paraquat lawsuits focus on claims that manufacturers failed to adequately warn agricultural workers and applicators about the neurological risks associated with repeated exposure to the chemical.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat lawsuit instantly.

Syngenta has announced it will stop manufacturing its paraquat-based weed killer by the end of June, a development that comes as the company faces thousands of lawsuits in the United States alleging the pesticide causes Parkinson’s disease.

Paraquat has been used in U.S. agriculture since the 1960s and is commonly applied to crops such as soybeans, corn, and cotton to control weeds.

However, more than 8,000 lawsuits have been filed nationwide by farmers, agricultural workers, and others who claim long-term exposure to paraquat contributed to the development of Parkinson’s disease.

Syngenta said its decision to exit the paraquat business was driven by market factors, including increased competition from generic manufacturers and the product’s relatively small contribution to the company’s overall sales.

The company did not reference the ongoing litigation in its announcement and continues to maintain that paraquat is safe when used according to label instructions.

Despite the company’s position, numerous scientific studies have linked paraquat exposure to damage in brain cells associated with Parkinson’s disease.

Plaintiffs in the litigation allege that Syngenta knew about potential neurological risks for decades but failed to adequately warn users or regulators.

The decision to discontinue production may add new attention to the ongoing lawsuits, which remain active in U.S. courts as attorneys continue negotiating potential settlements in thousands of pending claims.

Public health advocates say the move represents a significant step in addressing concerns about the herbicide’s safety.

However, experts note that generic versions of paraquat remain available from other manufacturers, meaning the chemical could continue to be used in U.S. agriculture unless regulators take further action.

The Paraquat litigation added 20 cases between February and March, increasing from 6,489 to 6,509.

The Paraquat lawsuits focus on claims that manufacturers failed to adequately warn agricultural workers and applicators about the neurological risks associated with repeated exposure to the chemical.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

A recent report from the River City Journalism Fund, published by St. Louis Public Radio, details how East St. Louis has become a focal point for Paraquat lawsuits filed against Syngenta and Chevron.

The cases center on allegations that manufacturers failed to warn users about alleged links between paraquat exposure and Parkinson’s disease.

In August 2023, attorneys filed a federal lawsuit in the U.S. District Court for the Southern District of Illinois in East St. Louis on behalf of Joe Harrison, an Oklahoma cattle rancher who applied paraquat-based herbicides for decades.

The complaint alleges that Syngenta’s product Gramoxone exposed Harrison to paraquat between 1997 and 2022 and that Syngenta failed to provide adequate warnings regarding the risk of Parkinson’s disease.

Harrison died months after filing suit.

An amended complaint continued the claims through his estate.

Syngenta has stated in court filings that there is no credible evidence that paraquat causes Parkinson’s disease.

East St. Louis now hosts nearly 6,500 Paraquat lawsuits consolidated into a multidistrict litigation.

Multidistrict litigation (MDL) is a federal procedure that centralizes similar lawsuits before one judge to coordinate pretrial proceedings and streamline discovery.

More than 1,600 additional cases are pending in Pennsylvania state court, along with hundreds in California and other jurisdictions. No bellwether trial has occurred to date.

A Virginia House subcommittee voted 6–5 to advance legislation to ban the sale and use of paraquat statewide, sending the proposal to the full House Agriculture Committee for further discussion.

If enacted, the bill would make Virginia the first state to enforce a complete ban on the herbicide.

The measure permits retailers to sell existing inventory, with a complete ban starting in July 2027.

Lawmakers backing the bill cited studies that connect paraquat exposure to Parkinson’s disease, expressing concerns about the risks to agricultural workers and nearby residents.

The vote comes as the EPA reviews paraquat again, requiring manufacturers to demonstrate the chemical’s safety under real-world conditions.

Agricultural industry representatives opposed the measure, telling lawmakers that paraquat is used on approximately 300,000 acres of Virginia farmland and remains an important weed management tool.

They contended that alternatives are less effective and would raise costs for farmers.

Pennsylvania lawmakers have proposed legislation to ban paraquat in the state, citing research that connects the herbicide to Parkinson’s disease and worries about its immediate toxicity.

State Senators Devlin Robinson and Nick Miller announced the proposal in January, making Pennsylvania one of at least nine states considering restrictions or outright bans, many of which focus on limiting use near schools.

The proposal comes as over 6,400 plaintiffs pursue paraquat lawsuits in the federal multidistrict litigation pending in the Southern District of Illinois.

The claims allege that Syngenta did not warn users that routine handling and application of paraquat can raise the risk of Parkinson’s disease, even if safety instructions are followed.

The legislative effort also follows recent developments in the litigation.

The first Philadelphia bellwether trial, involving claims brought by landscaper Bill Merten, was settled before trial when Syngenta reached an agreement.

In the federal MDL, Judge Nancy Rosenstengel continues to oversee coordinated proceedings, which remain stayed until March 6, 2026, as attorneys work toward a broader settlement framework announced last spring.

New York state legislators have introduced a bill to prohibit the sale and use of paraquat, a widely used herbicide linked in scientific studies to an increased risk of Parkinson’s disease and other serious health effects.

The proposed legislation is part of a growing effort by states to tighten regulation of toxic agricultural chemicals amid mounting public health concerns.

Sponsors of the bill cited emerging research and advocacy by health experts and affected individuals who argue that paraquat poses significant neurological risks that are foreseeable and preventable.

The proposal reflects worries that current federal and state oversight has not adequately protected farmworkers, applicators, and nearby communities from long-term exposure hazards associated with paraquat.

New York’s legislative proposal could influence both regulatory and legal landscapes, particularly as courts and policymakers evaluate whether stronger controls or outright bans are necessary to address the alleged risks.

If adopted, the law may intensify pressure on manufacturers defending paraquat claims and could serve as a model for other states considering similar restrictions or safety mandates.

U.S. health officials have announced an expanded review of paraquat, a widely used herbicide, amid mounting scientific evidence linking paraquat exposure to increased risk of Parkinson’s disease and other serious health effects. The review comes as thousands of plaintiffs nationwide pursue litigation against paraquat manufacturers, asserting that the companies failed to warn agricultural workers and consumers about the foreseeable neurological risks associated with exposure.

Federal agencies are evaluating whether paraquat should be subject to additional safety controls, labeling changes, usage restrictions, or even bans to better protect public health. The renewed scrutiny follows advocacy by health experts, consumer safety organizations, and affected individuals who argue that existing warnings are inadequate given epidemiological studies and medical research suggesting a strong association between paraquat exposure and the development of Parkinson’s disease.

The ongoing litigation mirrors broader trends in mass tort herbicide cases, where plaintiffs claim that chemical companies knew or should have known about serious toxicity risks yet continued to market and distribute products without sufficient hazard warnings or safeguards.

Paraquat cases join other high-profile herbicide lawsuits in state and federal courts, reflecting growing judicial engagement with product liability theories involving toxic exposure and chronic disease.

As regulatory review progresses, these developments could influence both future pesticide regulation and the course of existing paraquat litigation, including efforts by plaintiffs to obtain class certification, expert testimony on causation, and potential settlement negotiations with defendants.

The intersection of regulatory action and civil claims may shape how courts and manufacturers address foreseeable hazards tied to widely used agricultural chemicals.

The Paraquat MDL added 13 cases between January and February, increasing from 6,476 to 6,489.

Filing activity remains slow and incremental as the litigation stays in a mature phase.

The court continues to manage expert discovery and pretrial proceedings, with no new JPML developments reported.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

Syngenta has reached a settlement in the first scheduled bellwether trial for the Paraquat lawsuit.

The case was set to open in federal court in Philadelphia and would have marked the first public jury examination of claims that paraquat-based herbicides cause Parkinson’s disease.

The plaintiff alleged that occupational exposure to paraquat caused his Parkinson’s disease diagnosis.

The plaintiff operated a landscaping business during the 1980s and 1990s and regularly mixed and sprayed paraquat products, including Syngenta’s Gramoxone herbicide.

The complaint alleged exposure through inhalation and skin contact, even while using personal protective equipment.

The plaintiff was diagnosed with Parkinson’s disease in 2021.

The bellwether trial was expected to present decades of scientific studies and internal corporate documents addressing paraquat safety and potential neurological effects.

Syngenta disputes any causal link and states that credible scientific evidence does not support the claims.

Chevron is also named as a defendant because it distributed Syngenta’s paraquat products until 1986.

Chevron states that it should not be part of the litigation and denies liability.

Syngenta has resolved every paraquat case scheduled for trial prior to jury selection.

One prior multi-plaintiff settlement exceeded $187 million.

Additional Paraquat lawsuit trials remain scheduled later this year.

Philadelphia’s Court of Common Pleas is emerging as a central hub for paraquat herbicide litigation as 2026 begins.

Plaintiffs across the country have filed claims alleging that exposure to paraquat, a commonly used agricultural herbicide, has caused Parkinson’s disease and other serious neurological injuries.

These cases are being consolidated into coordinated proceedings to streamline pretrial activity and manage the large volume of filings, reflecting the growing complexity and scale of modern product liability litigation.

Paraquat claims follow a trend of chemical exposure lawsuits that have increasingly been brought in state courts, particularly in jurisdictions with established mass tort dockets.

Early filings indicate that these cases will play a major role in shaping Philadelphia’s mass tort calendar this year, influencing how courts handle discovery, pretrial motions, and potential settlements.

As litigation progresses, legal teams for both plaintiffs and defendants are preparing for extensive discovery and expert testimony, with the potential for multi-plaintiff trials.

The surge of paraquat cases underscores the broader focus on agricultural chemicals and the long-term health risks associated with repeated exposure, positioning Philadelphia as a key venue for mass tort developments in 2026.

U.S. Environmental Protection Agency (EPA) Administrator Lee Zeldin announced the agency will reassess the safety of the herbicide paraquat, requiring manufacturers to provide updated data demonstrating that current uses are safe under real-world conditions.

Paraquat, widely used on crops such as soybeans, corn, and cotton, is linked in multiple studies and lawsuits to Parkinson’s disease.

Syngenta, the primary U.S. manufacturer, faces thousands of claims from plaintiffs alleging neurological harm caused by paraquat exposure.

The EPA’s announcement follows ongoing regulatory reviews, including prior requests for manufacturers to provide data on chemical drift and bystander exposure.

The reassessment does not constitute an immediate ban, but reflects heightened scrutiny under scientific and legal pressure.

Paraquat remains banned in several countries due to its toxicity, but U.S. courts continue to see mass tort litigation related to exposure claims.

Plaintiffs’ attorneys cite the EPA’s review as a potential factor in pending and future cases.

The Environmental Protection Agency (EPA) has announced a new review of paraquat, a widely used herbicide linked to Parkinson’s disease.

EPA Administrator Lee Zeldin stated that manufacturers must demonstrate paraquat’s safety under real-world conditions, warning that failure to meet safety standards could result in decisive action.

Paraquat is highly toxic, with a single sip potentially fatal, and is banned in numerous countries, including Canada, China, and across the European Union.

Thousands of paraquat lawsuits allege a connection between exposure and the development of Parkinson’s disease, particularly among agricultural workers.

In 2021, paraquat manufacturer Syngenta settled a Parkinson’s-related case for approximately $187 million.

As of early 2026, roughly 6,400 federal lawsuits remain pending, with additional cases in state courts.

A tentative settlement agreement was reached in April 2025, but finalization has been repeatedly delayed, most recently until March 2026.

Legal experts suggest that the EPA’s renewed safety review could pressure Syngenta and plaintiffs to finalize the mass settlement, potentially resolving thousands of claims.

New Paraquat lawsuits continue to be filed by individuals diagnosed with Parkinson’s disease, even as the federal multidistrict litigation remains paused while settlement discussions progress.

More than 6,400 plaintiffs are now pursuing claims alleging long-term exposure to the herbicide Paraquat caused neurological damage and Parkinson’s disease.

The lawsuits argue manufacturers failed to warn farmers and agricultural workers about the risks, despite Paraquat’s extreme toxicity and bans in multiple countries.

The Paraquat litigation has been centralized in a federal MDL since 2021. In April 2025, the court stayed all pretrial proceedings after the parties reported they were nearing a potential global settlement.

That stay was set to expire in early 2026, but the court has now extended it through at least March 6, 2026.

Despite the pause, hundreds of new Paraquat Parkinson’s disease lawsuits have been added to the MDL during the stay, signaling continued growth and pressure on settlement negotiations.

If no agreement is reached, the court is expected to resume discovery and eventually schedule bellwether trials to test how juries respond to the evidence.

The Paraquat lawsuit recorded an increase in total multidistrict litigation (MDL) cases from December 2025 to January 2026.

The docket rose from 6,470 total cases in December 2025 to 6,476 in January 2026, resulting in six new filings during the month.

The Paraquat lawsuit involves claims that exposure to the herbicide paraquat caused Parkinson’s disease and other neurological injuries.

Plaintiffs allege that manufacturers failed to warn applicators and users about the risk of neurodegenerative harm associated with paraquat exposure.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

The federal judge overseeing the paraquat Parkinson’s MDL paused parts of the litigation in mid-2025 after the parties reported progress toward a broad settlement resolving many pending cases.

That pause expires in January, followed by a scheduled status conference.

So far, no final agreement has been announced, despite several extensions given to allow negotiations to proceed.

Over 6,400 cases are still active in the MDL, and key details remain unresolved, including how many plaintiffs will qualify for any settlement, the total dollar amount, and how payments will be divided among different types of claims.

While a previous 2021 Paraquat settlement resolved a smaller group of cases for around $187 million, the current negotiations are expected to cover a much larger portion of the docket.

Absent a finalized agreement, the January conference may indicate whether the case reverts to active litigation or whether the parties are nearing a settlement framework for court approval.

Meanwhile, new paraquat Parkinson’s lawsuits keep being filed, increasing pressure on both sides as the MDL nears a possible turning point in early 2026.

The Paraquat lawsuit recorded an increase in total multidistrict litigation (MDL) cases from November 2025 to December 2025.

The docket rose from 6,433 cases in November 2025 to 6,470 cases in December 2025, reflecting 37 new filings.

The Paraquat lawsuit involves claims that exposure to the herbicide Paraquat caused Parkinson’s disease and other neurological disorders.

Plaintiffs allege that manufacturers failed to provide adequate warnings regarding the risks of long-term or occupational exposure.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

The EPA is reopening its review of paraquat after getting new vapor-pressure data from Syngenta indicating the chemical might vaporize more easily than previously estimated.

The agency states that the study, submitted in January 2024, indicates a higher vapor pressure than was considered in previous risk assessments.

EPA’s internal review, completed in March 2024, found increased uncertainty about how paraquat moves off treated fields and could impact workers or nearby communities.

The agency plans to issue a data call-in to all manufacturers and will update its analysis after reviewing the new information.

EPA also intends to finish its Endangered Species Act and endocrine-disruption assessments before making a final decision on the registration review.

Separately, the U.S. Supreme Court rejected Syngenta’s petition to review paraquat product liability lawsuits related to Parkinson’s disease.

The October 6, 2025, denial leaves thousands of cases active, including many in the Pennsylvania state court.

Syngenta requested the Court to determine whether Pennsylvania’s business-registration statute improperly subjects out-of-state companies to general jurisdiction and promotes forum shopping.

With the petition denied, the lawsuit proceeds in the current venues.

The Paraquat MDL recorded a slight decline in filed cases, from 6,445 in October to 6,433 in November. 

Plaintiffs continue to allege that long-term exposure to the herbicide Paraquat caused Parkinson’s disease.

 The court has not yet set a bellwether trial date, but pretrial discovery and expert disclosures remain ongoing. 

Despite the decrease, the litigation remains active and closely watched.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

A federal judge overseeing multidistrict litigation alleging that the pesticide paraquat causes Parkinson’s disease has ordered attorney Aimee Wagstaff of Andrus Wagstaff PC to explain her plan to host a video conference for other lawyers in the case.

U.S. District Judge Nancy Rosenstengel expressed concern that Wagstaff—no longer on the plaintiffs’ executive committee—may be encouraging attorneys to reject a potential global settlement before its details are known.

The judge warned that no counsel will be allowed to undermine the court-supervised process and ordered Wagstaff to appear on October 14 to address possible sanctions.

The paraquat MDL, pending in the Southern District of Illinois since 2021, involves thousands of claims alleging the herbicide caused Parkinson’s disease.

Settlement talks have paused discovery and trial preparations until January 2026.

These developments come amid heightened scrutiny of paraquat’s safety and the ongoing effort to resolve the litigation globally.

The Paraquat litigation saw a modest increase in filed cases between September and October, rising from 6,362 to 6,445 total actions.

This net increase of 83 cases reflects the continued momentum in claims alleging that long-term exposure to the herbicide Paraquat may cause Parkinson’s disease.

Plaintiffs allege that manufacturers failed to warn users, especially agricultural workers and applicators, about the neurological risks linked to the widely used chemical.

With over 6,000 cases now consolidated in multidistrict litigation (MDL 3004), the bellwether process continues to move forward.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

A recent News Tribune feature spotlights William Caplinger, a lifelong Arkansas farmer who is battling Stage 4 prostate cancer after decades of exposure to farm chemicals, including the herbicide paraquat.

Caplinger believes that years of routine herbicide use contributed to his illness, a concern that reflects a broader nationwide issue: farmers across the United States may be exposed to dangerous agricultural chemicals without realizing the long-term health risks.

His story illustrates how everyday practices like spraying fields can quietly create serious medical consequences, prompting legal action across the country.

Thousands of farmers and agricultural workers have filed lawsuits linking paraquat exposure to Parkinson’s disease and other serious illnesses.

These cases are moving forward in federal and state courts, with early settlements and bellwether trials helping to shape the outcome.

As the litigation progresses, there is still time for affected farmers and others who suspect chronic chemical exposure has harmed their health to pursue claims.

THL continues to monitor developments and remains committed to keeping the agricultural community informed as these cases advance toward resolution.

The Paraquat multidistrict litigation (MDL) in the Southern District of Illinois recorded 6,362 pending cases in September, reflecting a slight increase from 6,331 cases in August.

The lawsuits allege that long-term exposure to Paraquat, a widely used herbicide, is linked to Parkinson’s disease and other serious health risks.

Plaintiffs claim manufacturers failed to adequately warn users about these dangers.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

The U.S. District Court for the Southern District of Illinois has extended key deadlines in the Paraquat product liability multidistrict litigation (MDL), as parties continue working to finalize a proposed settlement agreement.

Chief Judge Nancy J. Rosenstengel issued an order on August 12, 2025, extending the stay on case-specific discovery until September 26, 2025.

The extension comes after an April 2025 “Letter Agreement” between plaintiffs and defendants Syngenta and Chevron, which aimed to resolve a substantial portion of the more than 6,000 Parkinson’s disease lawsuits pending in the MDL.

The pause on deadlines also impacts three scheduled bellwether trial cases.

If a final settlement is not reached by the September deadline, discovery will resume and the first bellwether trial is set to begin October 14, 2025, followed by a second trial currently planned for April 6, 2026.

The MDL, centralized in Illinois since June 2021, involves claims that exposure to the herbicide Paraquat causes Parkinson’s disease.

Separate state court proceedings in jurisdictions such as California and Pennsylvania are continuing independently of the federal settlement negotiations.

The Paraquat MDL saw a slight decrease in total case count, dropping from 6,354 cases to 6,331 cases between July and August.

This adjustment may reflect updated docket corrections or dismissed claims.

Core allegations remain focused on long-term exposure to Paraquat and its link to Parkinson’s disease.

Discovery and expert work continue as the litigation progresses toward bellwether trials.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

A new bill introduced in Congress—the Pesticide Injury Accountability Act—could have a major impact on ongoing paraquat litigation by preserving victims’ ability to seek justice in federal court.

The proposed legislation would amend existing pesticide law to create a clear federal right of action for individuals harmed by toxic pesticide exposure, including Parkinson’s disease claims tied to paraquat.

Thousands of paraquat lawsuits are currently pending against Syngenta and other manufacturers, alleging that long-term exposure to the herbicide caused irreversible neurological damage.

The companies have sought to limit their liability by lobbying for legal immunity, a move that would effectively block many victims from pursuing compensation.

If passed, the Pesticide Injury Accountability Act would counter these efforts and prevent companies from avoiding responsibility through preemption or liability shields.

Supporters of the bill argue that pesticide manufacturers have long known about the serious risks associated with paraquat and other chemicals, yet failed to adequately warn the public or protect workers and communities.

The bill also follows a $187.5 million settlement reached by Syngenta in 2021 over paraquat-related claims—evidence, lawmakers say, of the need for stronger legal protections for those impacted by toxic exposure.

Pennsylvania regulators documented at least 18 cases where paraquat was mishandled between 2018 and 2023, including applications without required permits, missing protective gear or training, and spray drift off-target.

Investigators also flagged chronic health concerns: paraquat exposure has been linked in research to Parkinson’s disease, non-Hodgkin lymphoma, and childhood leukemia, adding urgency to tighter controls.

Paraquat is both acutely and chronically toxic; a very small swallowed dose can be fatal, and poison center data logged hundreds of U.S. exposure reports (including deaths) from 2016–2022.

Multiple epidemiology reviews report elevated Parkinson’s risk among applicators (some data show about 2.5-fold higher odds; a meta-analysis estimated a 64% increase), which is central to paraquat Parkinson’s lawsuits.

Internal company documents referenced in legal proceedings indicate manufacturers understood paraquat’s risks decades ago and worked to shape external research narratives—an issue now surfacing in Paraquat lawsuit discovery.

Regulatory pressure is building: a coalition in Pennsylvania introduced HB 1135 to ban paraquat sales and use statewide, and California enacted AB 1963 directing a multi-agency review that could lead to added restrictions.

At the federal level, EPA withdrew portions of its 2021 mitigation plan and reopened parts of the paraquat review, signaling that safety measures remain under active consideration.

Litigation is large and active: more than 6,300 Paraquat lawsuits alleging Parkinson’s disease are pending in multidistrict litigation before the U.S. District Court for the Southern District of Illinois, with bellwether trials scheduled and settlement talks reported.

A Philadelphia judge rejected Syngenta and Chevron’s attempt to exclude out-of-state plaintiffs from the city’s paraquat mass tort program.

The companies argued that cases involving non-Pennsylvania residents should be filed in other jurisdictions and questioned the court’s capacity to handle the volume of litigation.

The court denied the motion, permitting the coordinated docket to proceed with hearing claims from across the country.

Syngenta has reached a confidential settlement in a paraquat lawsuit filed by plaintiff Douglas Nemeth, a Pennsylvania man who alleged that long-term exposure to the herbicide caused him to develop Parkinson’s disease.

The agreement was finalized just weeks before the case was set to go to trial in Philadelphia, marking a significant development in ongoing litigation over the widely used weed killer.

Nemeth’s case was expected to be the first state court trial against Syngenta over paraquat-related Parkinson’s claims.

Although the specific terms of the settlement were not disclosed, the resolution is seen as part of a broader effort by Syngenta to avoid jury trials in similar cases.

The lawsuit was one of thousands filed across the U.S., with over 6,300 cases currently consolidated in a federal multidistrict litigation (MDL) in the Southern District of Illinois.

On April 5, 2024, Syngenta and plaintiffs’ counsel in the MDL submitted a letter of agreement outlining the framework for resolving a substantial number of these claims. U.S. District Judge Nancy Rosenstengel has since paused proceedings until late July 2025 to allow time for settlement discussions to proceed.

The first federal bellwether trial in the MDL is scheduled for October 2025.

It remains unclear whether the upcoming trial will proceed or be postponed, depending on the progress of ongoing settlement efforts.

Plaintiffs in the litigation allege that paraquat exposure significantly increases the risk of Parkinson’s disease and claim that Syngenta failed to warn users of the potential neurological dangers associated with the herbicide.

Syngenta maintains that paraquat is safe when used as directed and that the scientific evidence does not support the claimed link to Parkinson’s disease.

The Paraquat MDL increased to 6,354 cases in July, up from 6,159 in June.

The litigation centers on allegations that exposure to the herbicide caused Parkinson’s disease.

Plaintiffs continue to push for the admission of expert testimony linking Paraquat to neurodegenerative harm, while defendants challenge the reliability of that science.

Recent case activity includes scheduling updates and Daubert briefings, with the court preparing to rule on key motions that could shape the scope of future bellwether trials.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

The court handling the federal Paraquat Parkinson’s disease litigation has extended the pause on case-specific discovery until July 21, 2025, as settlement negotiations continue.

No details have been released about potential average payouts for plaintiffs, despite a tentative agreement first disclosed in April.

Over 6,000 lawsuits are pending against Syngenta and Chevron, consolidated in the U.S. District Court for the Southern District of Illinois before Judge Nancy Rosenstengel.

Plaintiffs claim that exposure to Paraquat caused Parkinson’s disease and that the manufacturers did not warn about the risks.

The current stay impacts the second set of bellwether trials, scheduled for October 2025 and April 2026.

These cases remain in pretrial stages after Judge Rosenstengel dismissed the first bellwether group last year, following the exclusion of key expert testimony.

The new bellwether pool involves different expert witnesses, but it’s uncertain whether those trials will proceed if a settlement isn’t reached soon.

The judge in the Paraquat MDL dismissed 116 cases after plaintiffs failed to submit Plaintiff Assessment Questionnaires, despite being given multiple chances to comply.

The dismissals follow a structured process detailed in Case Management Order No. 10, which included multiple notices and extensions.

One plaintiff evaded dismissal by demonstrating that communication issues contributed to the delay, and the court concurred that the case would probably be refiled if dismissed.

The decision underscores the risks of noncompliance in mass tort proceedings—missing deadlines can compromise settlement leverage and impede case progress.

Attorneys are expected to inform the court about the status of the Paraquat settlement during the next hearing.

The Paraquat MDL grew by 123 cases between May and June, reaching a total of 6,159 plaintiffs.

New filings continue to come from agricultural workers, pesticide applicators, and rural residents alleging that long-term exposure to the herbicide caused Parkinson’s disease.

Many recent complaints include affidavits from neurologists and occupational health specialists, along with work histories tracing paraquat use back decades.

Lawyers are pushing for additional corporate discovery into historical safety testing and internal communications regarding paraquat’s neurotoxicity, as case-specific discovery begins in select plaintiff groups.

A bellwether trial schedule has yet to be finalized.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

Judge Nancy Rosenstengel has postponed all case-specific discovery deadlines in the Paraquat MDL until June 11, 2025, giving lawyers more time to finalize the terms of a proposed global settlement.

The pause follows a joint motion filed with the Seventh Circuit in April, when both sides indicated they were close to resolving thousands of claims related to Parkinson’s disease.

The stay does not affect the trial dates currently scheduled for October 2025 and April 2026.

However, if the settlement talks fail, it remains uncertain whether the trials will proceed as scheduled.

The Court has identified three bellwether cases for the initial trial.

Plaintiffs are still awaiting details about potential payout structures and eligibility.

The Paraquat lawsuit centers on claims that prolonged exposure to the herbicide Paraquat has led to the development of Parkinson’s disease and other serious neurological conditions.

Plaintiffs allege that manufacturers failed to warn agricultural workers and others about the dangers of handling the chemical.

125 cases have been added to the Paraquat MDL in the past month.

211 cases total have been added to the litigation since January 1st.

As more individuals become aware of the alleged link between Paraquat and neurological damage, the number of claims continues to grow.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

Syngenta has reached a settlement agreement aimed at resolving a large portion of the lawsuits pending against it over claims that its paraquat-based weedkiller causes Parkinson’s disease.

The announcement was made in a court filing this week and confirmed during a federal hearing, with lead plaintiffs’ attorneys indicating that the terms of the settlement should be finalized within 30 days.

As of mid-April, more than 5,800 lawsuits were consolidated in a federal multidistrict litigation (MDL) in Illinois, with hundreds more pending in state courts like California.

While the agreement would not resolve every case, it is expected to settle a significant share of the claims brought by individuals exposed to paraquat.

Syngenta maintains that paraquat is safe and denies any wrongdoing, stating that decades of research and over 1,200 scientific studies have not definitively proven a causal link between paraquat and Parkinson’s.

Still, the company acknowledged that continuing litigation is both distracting and expensive.

Some attorneys representing clients outside the MDL expressed frustration at being excluded from settlement talks and warned that the agreement could delay or undermine their own clients’ cases.

Concerns remain over transparency and whether the terms will offer meaningful relief to all plaintiffs.

This move comes as lawmakers and public health advocates push for stricter regulations—or a full ban—on paraquat use, citing mounting scientific evidence and internal documents suggesting Syngenta was aware of neurological risks for years.

The settlement is being closely watched, not only for its potential to resolve thousands of claims but also for its broader impact on future chemical safety litigation.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

In the United States District Court for the Southern District of Illinois, the court has begun preparing a select group of cases for trial.

Six cases have been identified for full case-specific discovery and will proceed towards trial.

The court has scheduled trial dates for October 14, 2025 and April 6, 2026 along with setting the schedule for pretrial motions and discovery.

These bellwether trials will be the first trials in this litigation.

A bellwether trial refers to a trial setting of representative cases selected from the larger group of Paraquat cases.

The purpose of a bellwether trial is to gauge how the court and a jury will respond to the evidence and arguments presented by both the plaintiffs and the defendants.

The outcomes of these cases can provide guidance for the parties on how to proceed in the overall litigation or affect the resolution of other cases.

The vetting process for bellwether trial case selection is extensive, with efforts made to select cases that are representative of the filed cases.

In addition to the federal MDL, Paraquat cases are also being litigated in California state court.

Filing in multiple jurisdictions can be a powerful strategy because it increases pressure on the defendant and forces them to defend themselves in several places at once.

THL has cases filed in both forums and actively litigates in each.

As you may recall, we reported last year that the federal court excluded Plaintiffs’ primary causation expert witnesses, which resulted in the dismissal of four cases.

Those rulings are currently on appeal, and new witnesses have been developed to give testimony in future cases.

In December, the same causation expert was excluded in cases filed in the California state court actions.

While this presents another challenge, our team is working diligently to identify additional qualified experts to support the scientific basis of the claims.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

The Paraquat Lawsuit experienced a slight increase in filings between March and April 2025.

In March, there were 5,859 Paraquat Lawsuits filed in the MDL.

By April 1st, this number has risen to 5,911 Paraquat Lawsuits, marking an increase of 52 new cases.

The Paraquat Lawsuit involves individuals who have suffered harm due to the use of Paraquat, a toxic herbicide, and its alleged links to serious health conditions, including Parkinson’s disease.

Paraquat has long been associated with significant health risks, and the ongoing litigation seeks justice for those affected.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

Recent research has revealed alarming findings about the risks posed by exposure to multiple pesticides, including paraquat, particularly in agricultural regions.

The study, which analyzed 2,500 pediatric cancer cases in Nebraska, found that exposure to pesticide mixtures increased the risk of brain cancer, leukemia, and overall childhood cancers.

Specifically, a 10% mixture of commonly used herbicides, including paraquat, glyphosate, and dicamba, increased brain cancer rates by 36% and leukemia rates by 23%.

While previous studies have focused on individual pesticides, this groundbreaking research underscores the dangers of pesticide mixtures, a reality ignored by existing regulatory structures that treat each chemical exposure in isolation.

Children, who are more vulnerable to toxins due to their smaller size and ongoing development, face significant risks from even low levels of exposure.

Furthermore, pesticide contamination is not confined to agricultural workers but affects broader populations, particularly through food and water.

The study’s authors highlight the need for a reevaluation of how pesticides, including paraquat, are regulated, emphasizing that the current approach fails to account for the cumulative toxic effects of multiple chemicals.

While long-term solutions require policy changes, individuals can reduce their exposure by purchasing organic foods and investing in effective water filtration systems.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

In March 2025, the number of new Paraquat Lawsuit filings reached 5,859, marking an increase of 21 cases from the 5,838 recorded in February 2025.

As plaintiffs across the nation file lawsuits, they allege that exposure to the herbicide caused the onset of Parkinson’s and other neurological disorders.

Despite the relatively small increase in cases, the ongoing awareness of Paraquat’s health risks is likely encouraging more individuals affected by the chemical to seek legal recourse.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

The Seventh Circuit Court of Appeals is reviewing whether to reinstate four Paraquat Lawsuits that were previously set for bellwether trials but dismissed after a judge barred expert testimony linking Paraquat exposure to Parkinson’s disease.

Plaintiffs argue that their experts were unfairly excluded and that the ruling should have been left to a jury, while manufacturers maintain that no conclusive peer-reviewed research confirms the connection.

As the appeal moves forward, Judge Nancy Rosenstengel is advancing a new group of bellwether cases, with the first trial scheduled for October 14, 2025, and a second set for April 6, 2026.

While these trials will not determine the fate of other claims, they are expected to influence future Paraquat settlements as more than 5,800 lawsuits proceed through the MDL in the Southern District of Illinois.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

The EPA’s final report on Paraquat’s safety, originally scheduled for release by January 17, 2025, has been delayed.

The agency has withdrawn its interim regulatory decision, citing the need for additional time to assess Paraquat’s safety.

Despite being banned in over 70 countries, the product has remained on the market since the 1960s, raising questions about why more comprehensive studies were not conducted earlier.

The EPA now requires additional years to review the data before making a final decision.

While a ban would have significantly supported Plaintiffs in the Paraquat Mass Torts, the litigation will proceed as scheduled, with the first trial set to begin in the coming months.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

In the latest developments in the Paraquat MDL, Judge Rosenstengel has selected six cases for full case-specific discovery.

These cases have been divided into two groups: the first group of three will go to trial on October 15, 2025, while the second group is scheduled for trial on April 6, 2026.

Fact discovery is set to be completed by March 21, 2025, with Summary Judgment and Daubert motions due on August 15, 2025.

Additionally, the Paraquat bellwether trial in Philadelphia has been delayed by two months, now set to begin in June 2025.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

In February 2025, the number of Paraquat cases rose to 5,838, an increase of 13 filings compared to the 5,825 cases reported in January 2025.

This uptick, while modest, signals the continued growth of litigation related to Paraquat exposure and its association with Parkinson’s disease.

As plaintiffs across the nation file lawsuits, they allege that exposure to the herbicide caused the onset of Parkinson’s and other neurological disorders.

Despite the relatively small increase in cases, the ongoing awareness of Paraquat’s health risks is likely encouraging more individuals affected by the chemical to seek legal recourse.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

The Paraquat Parkinson’s disease litigation is entering a pivotal stage as key legal battles unfold in Philadelphia and the multidistrict litigation (MDL).

• Key Deadlines: Responses to motions to exclude experts and summary judgment are due next week, with reply briefs expected by the end of February.
• Oral Arguments & Trial Schedule: Oral arguments are set for March, followed by the first paraquat trial, scheduled to begin in April.
• MDL Developments: The court has identified the next batch of 10 bellwether cases, and Judge Rosenstengel has scheduled the next case management conference (CMC) for April 11, 2025—coinciding with the first trial in Philadelphia.

This raises questions about whether the April CMC will focus on the Philadelphia trial’s progress or if other strategic developments in the MDL will take precedence.

The coming months will be critical in shaping the future of the paraquat litigation.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

Despite being banned in 70 countries, paraquat remains legal in the United States, raising concerns among health and environmental advocates.

The herbicide, linked to Parkinson’s disease and other serious health issues, was reapproved for use by the Environmental Protection Agency (EPA) in 2024.

Earthjustice, along with farming and environmental organizations, has filed a lawsuit challenging the EPA’s decision.

Under California law, the agency is required to reassess its approval.

A preliminary investigation by the California Department of Pesticide Regulation confirmed paraquat’s association with human health risks, including neurodegenerative diseases and cancer.

The report also highlighted potential harm to wildlife, including endangered species such as the San Joaquin kit fox and Swainson’s hawk.

“The evidence continues to mount that paraquat is just too dangerous,” said Jonathan Evans, environmental health legal director at the Center for Biological Diversity.

While calls for a ban are growing, the full evaluation of paraquat’s risks is not expected to be completed until January 2029.

Critics argue that delaying action could expose more people and wildlife to unnecessary harm.

Pesticides like paraquat not only threaten human health but also contribute to biodiversity loss and ecosystem degradation.

Advocacy groups urge stronger regulations, while consumers can support organic farming and sustainable agriculture to reduce reliance on toxic chemicals.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

The U.S. Environmental Protection Agency (EPA) is set to release a document reassessing the risks of paraquat, a widely used herbicide linked to Parkinson’s disease, by the end of this week.

The update comes after years of growing scientific evidence and legal battles over the chemical’s potential dangers.

Studies, including a 2024 epidemiological analysis, suggest that paraquat exposure doubles the risk of developing Parkinson’s for those living or working near areas where the herbicide is applied.

Researchers cite evidence from lab studies, animal models, and human data linking paraquat to the neurodegenerative disease.

Paraquat is banned in over 70 countries, including the European Union, China, and Brazil.

However, U.S. usage has surged, driven by its effectiveness against glyphosate-resistant weeds.

The EPA provisionally reapproved paraquat in 2021, prompting lawsuits from advocacy groups, including the Michael J. Fox Foundation.

These groups argue that the EPA failed to adequately consider scientific evidence during its review.

Syngenta, paraquat’s primary manufacturer, maintains that the herbicide is safe when used properly, citing studies that found no significant risk.

Critics argue these studies lack sufficient controls and rely on self-reported data.

The EPA’s upcoming reassessment will weigh the latest research, including new evidence submitted since its last review.

Advocacy groups stress that a failure to ban or severely restrict paraquat would leave thousands vulnerable to preventable health risks.

The EPA’s decision could have far-reaching implications, potentially influencing regulatory standards, ongoing lawsuits, and public health policies related to paraquat and other hazardous herbicides.

If the agency’s conclusions fail to address advocates’ concerns, the battle over paraquat’s safety is expected to intensify in the courts.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

This week marks a critical juncture in the ongoing Paraquat litigation in Philadelphia, as parties file motions for summary judgment and to exclude expert testimony.

These motions aim to narrow the issues before trial by addressing legal standards and evidentiary challenges.

What is Summary Judgment?

A motion for summary judgment asks the court to resolve parts of a case—or the entire case—without proceeding to a jury trial.

The moving party argues that there are no factual disputes requiring a jury’s decision and that the law supports their position.

If granted, this can significantly reduce the scope of the trial or even lead to its dismissal.

In the Paraquat litigation, plaintiffs allege that exposure to the herbicide caused them to develop Parkinson’s disease.

Expert testimony is crucial to proving these claims, as it connects the use of Paraquat to the alleged injuries.

The motions to exclude expert testimony will challenge the qualifications, methodology, or relevance of the plaintiffs’ experts.

The outcome of these filings could shape the course of the litigation, determining which claims proceed to trial and what evidence can be presented to a jury.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

The number of Paraquat Lawsuits pending in the Paraquat MDL has slightly decreased from 5,835 in December to 5,825 in January 2025, reflecting a reduction of 10 cases.

Paraquat, a herbicide linked to Parkinson’s disease, continues to be the subject of ongoing litigation as more individuals who developed the disease after exposure seek legal recourse.

The slight decline in case filings may indicate a stabilization in the number of new claims being filed or a temporary slowdown in the legal process.

However, the overall high volume of Paraquat Lawsuits remains significant, highlighting the ongoing impact of Paraquat exposure on those affected by the herbicide’s toxic effects.

Legal developments in the Paraquat Lawsuit continue to focus on the responsibility of the manufacturers and distributors of the herbicide.

As litigation progresses, further case filings and developments are expected, and the overall trend of legal action surrounding Paraquat may continue to evolve as more individuals come forward to join the lawsuits.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

47 Cases at Risk of Dismissal from MDL

Randy Ellis, the Special Master overseeing the Paraquat MDL, has issued a report with recommendations concerning plaintiffs who have not submitted the required Plaintiff Assessment Questionnaires (“PAQ”).

In the report, Ellis highlights a group of 47 plaintiffs who have entirely failed to submit their PAQs, despite multiple opportunities.

The Special Master has advised the court to dismiss these cases without prejudice.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

The U.S. District Court handling the Paraquat Lawsuit will hold a status conference on December 19, 2024, to assess progress on the litigation and review case summaries submitted for the next round of bellwether trials.

Paraquat Lawsuits allege that Syngenta and Chevron failed to warn users of the herbicide’s link to Parkinson’s disease, with more than 5,800 cases currently consolidated in a multidistrict litigation (MDL) before Judge Nancy J. Rosenstengel in the Southern District of Illinois.

Judge Rosenstengel has been working since 2021 to advance bellwether trials aimed at testing the strength of evidence and expert testimony.

A first set of bellwether cases was dismissed earlier this year after the court excluded the plaintiffs’ expert witness testimony, leaving those claimants unable to establish a direct connection between their Parkinson’s diagnoses and Paraquat exposure.

In August 2024, the court selected 10 new lawsuits for case-specific discovery.

These cases rely on different expert witnesses than the dismissed claims. Lawyers for each case were required to submit a one-page summary by December 16, detailing the key issues and evidence for review.

The upcoming December 19 status conference will address:

• Review of the newly submitted bellwether case summaries.
• Updates on discovery progress for the 10 selected cases.
• Potential scheduling for the first Paraquat bellwether trial, though no trial dates have yet been confirmed.

Bellwether trials are expected to gauge how juries respond to the evidence and help shape potential settlement discussions.

If no settlement is reached, cases may be remanded to their original districts for individual trials.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

The Environmental Working Group (EWG) has renewed its call for the Biden administration to ban Paraquat, a widely used herbicide linked to an increased risk of Parkinson’s disease.

Already banned in over 70 countries, Paraquat continues to pose serious health risks to farmworkers and rural residents in the U.S., sparking demands for immediate regulatory action.

Advocates argue that banning Paraquat would build on President Biden’s chemical safety legacy, following actions against PFAS, asbestos, and chlorpyrifos.

Scientific evidence has increasingly linked Paraquat exposure to severe health conditions, emphasizing the need for the U.S. to align with global safety standards.

The EPA faces mounting pressure to take decisive action, as the continued use of Paraquat underscores the urgent need to protect public health and vulnerable communities.

If you’ve developed Parkinson’s disease after being exposed to Paraquat dichloride, you may be eligible to file a Paraquat Lawsuit and seek financial compensation.

Contact the Paraquat Lawyers at TorHoerman Law for a free consultation.

Use the chat feature on this page for a free case evaluation to find out if you qualify for the Paraquat Lawsuit instantly.

The Judicial Panel on Multidistrict Litigation (JPML) reported 5,818 case filings for the Paraquat lawsuit in November.

By December, the number of case filings increased to 5,835, reflecting a growth of 17 cases.

The Paraquat lawsuit involves claims that exposure to the herbicide Paraquat has been linked to the development of Parkinson’s disease and other serious health conditions.

This slight increase in filings may result from ongoing awareness efforts, recent medical studies, or attorneys identifying additional claimants eligible to join the litigation.

The Paraquat multidistrict litigation continues to expand as new plaintiffs file claims against manufacturers alleging failure to warn about the product’s dangers.

Contact TorHoerman Law for a free consultation to discuss your legal options and talk to a Paraquat Lawyer about filing a lawsuit.

Want to find out if you qualify for the Paraquat Lawsuit right away? 

Use our chatbot on this page to receive a free instant online case evaluation right now.

Earlier setbacks in the Paraquat MDL included the exclusion of the Plaintiffs’ general causation expert, impacting the progress of the case.

However, the MDL Judge has since selected 10 new bellwether cases for discovery, initially chosen in August 2024.

After two cases were voluntarily dismissed, substitution cases were brought in, and discovery efforts are actively moving forward.

Meanwhile, in Philadelphia, cases are advancing with exchanged expert reports.

Key dates include motions for summary judgment and to exclude experts, both due on December 4, 2024.

Oral arguments are anticipated in early 2025, with a trial date set for April 2025.

As the scheduled trial approaches, all eyes are on Philadelphia to determine if the Plaintiffs can overcome the Defendants’ challenges and proceed to trial.

Contact TorHoerman Law for a free consultation to discuss your legal options and talk to a Paraquat Lawyer about filing a lawsuit.

Want to find out if you qualify for the Paraquat Lawsuit right away?

Use our chatbot on this page to receive a free instant online case evaluation right now.

More than 50 U.S. lawmakers have called on the Environmental Protection Agency (EPA) to ban paraquat, a widely used weedkiller, citing significant health and environmental concerns.

In a letter sent on October 31, seven U.S. senators argued that the pesticide, commonly applied on U.S. farms, is a “highly toxic” substance whose continued use is unjustifiable, given its potential to cause serious harm to farmworkers and rural communities.

This letter followed an earlier appeal from 47 members of the U.S. House of Representatives, urging the same action.

Lawmakers highlighted growing scientific evidence linking paraquat exposure to serious health conditions, particularly Parkinson’s disease.

Studies show that exposure to the chemical increases the likelihood of developing Parkinson’s by as much as 64%, along with other life-threatening diseases such as non-Hodgkin’s lymphoma and thyroid cancer.

The EPA has long maintained that there is no “clear link” between paraquat and Parkinson’s disease, though it acknowledges the chemical’s acute toxicity and has implemented some restrictions on its use.

In 2024, the agency issued a draft report affirming its stance, though it promised to review more studies and issue a final report by January 2025.

Despite this position, pressure is mounting both at the federal and state levels. 

The debate continues as the EPA reviews the latest scientific evidence, with a decision expected in early 2025.

Contact TorHoerman Law for a free consultation to discuss your legal options and talk to a Paraquat Lawyer about filing a lawsuit.

Want to find out if you qualify for the Paraquat Lawsuit right away? 

Use our chatbot on this page to receive a free instant online case evaluation right now.

Ten cases have been selected for case-specific discovery for the purpose of trial preparation in the Paraquat MDL.

Case-specific discovery includes the parties trading documents and factual information through things such as written questions and answers, medical records, licensing records, etc.

Case-specific discovery for these 10 cases also includes the taking of depositions of the plaintiffs, witnesses (who testify about the plaintiff’s use of Paraquat), damages witnesses (who testify to the effect Parkinson’s disease has had on the plaintiff), and treating healthcare providers.

In December, the court will select a subset of these cases for additional discovery involving expert reports and testimony, after which we expect trials to be set.

Earlier this year, the court excluded Plaintiffs’ primary causation expert witnesses, which resulted in the dismissal of four cases.

Those rulings are currently on appeal, and new witnesses have been developed to give testimony in future cases.

Contact TorHoerman Law for a free consultation to discuss your legal options and talk to a Paraquat Lawyer about filing a lawsuit.

Want to find out if you qualify for the Paraquat Lawsuit right away? 

Use our chatbot on this page to receive a free instant online case evaluation right now.

The Paraquat Parkinson’s Disease Lawsuit centers on claims that exposure to the herbicide Paraquat is linked to an increased risk of developing Parkinson’s disease and other serious health conditions.

Plaintiffs allege that manufacturers failed to properly warn users, particularly agricultural workers, about the dangers of long-term exposure to Paraquat.

In October, 5,883 cases were filed in connection with the Paraquat lawsuit, which slightly decreased to 5,818 in November, a reduction of 65 cases.

This decrease may be due to case consolidations or other procedural adjustments as the litigation progresses.

Exposure to Paraquat has been associated with neurotoxic effects, contributing to the onset of Parkinson’s disease, which can significantly impact a person’s mobility, quality of life, and long-term health.

If you or a loved one were exposed to Paraquat and subsequently diagnosed with Parkinson’s Disease or other related health conditions, you may be eligible to file a Paraquat Lawsuit.

A coalition of 47 members of Congress, led by Rep. Greg Casar from Texas, has called on the U.S. Environmental Protection Agency (EPA) to ban the herbicide paraquat, citing its severe risk to human health and the environment.

In a letter sent to EPA Administrator Michael S. Regan, the lawmakers expressed concerns about the continued use of paraquat, linking the herbicide to life-threatening diseases like Parkinson’s disease, non-Hodgkin’s lymphoma, and thyroid cancer.

They also highlighted its role in soil and water pollution, noting that paraquat can persist in the environment for years before breaking down.

The herbicide is currently the subject of multidistrict litigation in Illinois federal court, and lawmakers are urging the EPA to follow the lead of more than 70 countries, including China, Brazil, Canada, and the European Union, which have already banned or discontinued paraquat’s use.

Supporting this initiative, Geoff Horsfield, policy director for the Environmental Working Group, stated that safer alternatives exist, and that banning paraquat would protect farmers and farmworkers.

He urged the Biden Administration’s EPA to act, stating “Seventy countries have banned paraquat, so we know that farmers have plenty of safer options.”

Contact TorHoerman Law for a free consultation to discuss your legal options and talk to a Paraquat Lawyer about filing a lawsuit.

Want to find out if you qualify for the Paraquat Lawsuit right away? 

Use our chatbot on this page to receive a free instant online case evaluation right now.

California has taken significant steps to address the dangers of the toxic herbicide paraquat with the recent signing of Assembly Bill 1963 by Governor Gavin Newsom.

The new law mandates the state’s Department of Pesticide Regulation (DPR) to expedite its reevaluation of paraquat, a weedkiller linked to severe health issues, including Parkinson’s disease and cancer.

The reevaluation, which is now prioritized, must be completed by January 1, 2029, potentially leading to the herbicide being banned or subjected to stricter regulations.

This legislative push is part of a broader effort, supported by advocacy groups like the Environmental Working Group (EWG) and The Michael J. Fox Foundation, to address the growing evidence linked paraquat exposure to serious health risks.

These groups are also calling on the U.S. Environmental Protection Agency (EPA) to take similar action and ban paraquat nationwide, joining over 70 other countries, including the European Union and China, that have already done so.

Governor Newsom also signed A.B. 2113, which provides DPR with additional resources to speed up scientific reevaluations of toxic pesticides through increased registration and sales fees, highlighting the state’s commitment to tackling harmful chemicals in agriculture.

Contact TorHoerman Law for a free consultation to discuss your legal options and talk to a Paraquat Lawyer about filing a lawsuit.

Want to find out if you qualify for the Paraquat Lawsuit right away? 

Use our chatbot on this page to receive a free instant online case evaluation right now.

The Paraquat litigation, involving claims that exposure to the herbicide causes Parkinson’s disease, continues to see significant activity.

Paraquat, a widely used chemical in agriculture, has been linked to serious health risks, including neurological damage.

The lawsuits allege that manufacturers failed to warn consumers of these risks.

In September, there were 5,891 active Paraquat lawsuits filed under the Judicial Panel on Multidistrict Litigation (JPML).

By October, that number slightly decreased to 5,883, reflecting a drop of 8 cases.

Despite this decrease, the total number of lawsuits remains high, indicating continued concern over Paraquat’s harmful effects on individuals exposed to the chemical.

Paraquat exposure is particularly dangerous to farmers, agricultural workers, and those living near treated areas.

Contact TorHoerman Law for a free consultation to discuss your legal options and talk to a Paraquat Lawyer about filing a lawsuit.

Want to find out if you qualify for the Paraquat Lawsuit right away?

Use our chatbot on this page to receive a free instant online case evaluation right now.

Paraquat, a herbicide linked to Parkinson’s disease, remains a focal point in ongoing legal and policy debates.

As the California State Assembly concluded its 2024 legislative session, an original bill to ban paraquat was amended to require the California Department of Pesticide Regulation to conduct an expedited review, with a deadline of January 1, 2029.

Environmental and public health advocates continue to push for an emergency suspension of paraquat, similar to the recent U.S. Environmental Protection Agency (EPA) ban on the herbicide Dacthal.

Scientific studies consistently demonstrate the severe health risks of paraquat exposure.

A 2020 study linked exposure to increased Parkinson’s disease cases, with data pinpointing risk areas by zip code.

A 2019 meta-analysis confirmed a significant increase in Parkinson’s disease risk from cumulative paraquat exposure.

The EPA is currently reviewing paraquat following a lawsuit filed by Earthjustice, with a final report expected in 2025.

The legal proceedings in the Paraquat MDL are also progressing. 

The court has scheduled motions practice, with plaintiffs set to file their omnibus response to the defendants’ motion to dismiss by November 11, 2024.

Defendants are required to file their omnibus reply by December 2, 2024, and any individual plaintiffs may file responses by that date as well.

Additionally, on September 17, 2024, the Michael J. Fox Foundation spearheaded a national Day of Action, calling on the public to urge Congress to pressure the EPA to cancel paraquat’s registration ahead of the 2025 deadline.

Furthermore, public health advocates and farmworkers are urging the EPA to ban paraquat.

Despite being banned in over 70 countries, paraquat remains in use in the U.S., with the EPA set to decide on its license renewal by January 2025.

Contact TorHoerman Law for a free consultation to discuss your legal options and talk to a Paraquat Lawyer about filing a lawsuit.

Want to find out if you qualify for the Paraquat Lawsuit right away?

Use our chatbot on this page to receive a free instant online case evaluation right now.

A recent study published in the journal Ecotoxicology and Environmental Safety provides further evidence that exposure to the herbicide Paraquat may lead to Parkinson’s disease.

Conducted by researchers from Ningxia Medical University School of Public Health, the study tested human neuroblastoma cell lines and found that exposure to Paraquat resulted in the buildup of α-synuclein (α-syn), a protein linked to neurodegenerative diseases like Parkinson’s.

The researchers noted that the brain’s inability to clear amyloid proteins efficiently is a recognized factor in the development of these diseases.

This new research strengthens the argument that Paraquat exposure can cause Parkinson’s disease, supporting the claims made in thousands of lawsuits currently pending in U.S. courts.

The Paraquat Products Liability Litigation continues to grow as more individuals file claims alleging exposure to the herbicide Paraquat has caused Parkinson’s disease and other serious health issues.

In August 2024, there were 5,757 active cases within the Paraquat Products Liability Litigation.

This number has increased to 5,891 as of September 2024, reflecting a sizable increase in case filings.

The increase in filings indicates a growing awareness among potential plaintiffs regarding the alleged risks associated with Paraquat exposure.

These lawsuits, centralized in multidistrict litigation (MDL) under U.S. District Judge Nancy J. Rosenstengel in the Southern District of Illinois, allege that agricultural workers, farmers, and landscapers exposed to Paraquat developed Parkinson’s disease due to inadequate warnings about the herbicide’s neurological risks.

The court has initiated a “bellwether” process to prepare a small group of representative cases for trial, which will help determine how juries might respond to evidence in the broader litigation.

Contact TorHoerman Law for a free consultation to discuss your legal options and talk to a Paraquat Lawyer about filing a lawsuit.

Want to find out if you qualify for the Paraquat Lawsuit right away?

Use our chatbot on this page to receive a free instant online case evaluation right now.

An Illinois federal judge decided not to dismiss several cases in the ongoing multidistrict litigation (MDL) concerning the herbicide paraquat.

This decision came despite the fact that the plaintiffs’ counsel failed to submit required questionnaires on time.

The judge recognized that the delays were due to the attorney being left as the sole practitioner at his firm after other attorneys had quit, thereby allowing the cases to proceed.

Contact TorHoerman Law for a free consultation to discuss your legal options and talk to a Paraquat Lawyer about filing a lawsuit.

Want to find out if you qualify for the Paraquat Lawsuit right away?

Use our chatbot on this page to receive a free instant online case evaluation right now.

A comprehensive study published in Frontiers in Cancer Control and Society has established a significant link between agricultural pesticide use and increased cancer risk across various types.

The study used county-level data to analyze pesticide usage patterns and their correlation with cancer incidence.

The study found strong associations between pesticide exposure and cancers such as leukemia, non-Hodgkin’s lymphoma, bladder, colon, lung, and pancreatic cancers.

Pesticides like Glyphosate, Atrazine, Boscalid, and Dicamba were linked to higher incidences of various cancers.

Outside of this study, Paraquat has been under scrutiny due to its potential health risks, including Parkinson’s disease.

There have been numerous lawsuits against manufacturers of Paraquat, with plaintiffs claiming that exposure to the herbicide led to their Parkinson’s disease diagnoses.

Contact TorHoerman Law for a free consultation to discuss your legal options and talk to a Paraquat Lawyer about filing a lawsuit.

Want to find out if you qualify for the Paraquat Lawsuit right away? Use our chatbot on this page to receive a free instant online case evaluation right now.

In a significant development for the Paraquat multidistrict litigation (MDL), the Judge has recently selected ten new cases to serve as bellwether trials.

This decision comes after a major setback in April when all previously selected cases were dismissed, causing considerable delays as parties had spent over a year preparing these cases for trial.

The newly selected bellwether cases will undergo case-specific fact discovery over the next few months in preparation for possible jury trials.

This process is crucial in moving the litigation forward and potentially setting precedents in future cases.

Despite this progress, there is a strong suspicion that a global settlement may be reached before any of these bellwether trials commence.

The selection and preparation of these cases put additional pressure on the defendants, potentially promoting settlement negotiations.

Contact TorHoerman Law for a free consultation to discuss your legal options and talk to a Paraquat Lawyer about filing a lawsuit.

Want to find out if you qualify for the Paraquat Lawsuit right away? 

Use our chatbot on this page to receive a free instant online case evaluation right now.

The Paraquat Lawsuit involves claims against manufacturers of Paraquat, a widely used herbicide.

Plaintiffs allege that exposure to Paraquat increases the risk of developing Parkinson’s disease.

In July, there were 5,770 filings in the Paraquat Herbicide lawsuit.

By August, this number slightly decreased to 5,757 filings.

Exposure to Paraquat can lead to severe health issues, prompting many affected individuals to file lawsuits against the manufacturers.

Contact TorHoerman Law for a free consultation to discuss your legal options and talk to a Paraquat Lawyer about filing a lawsuit.

Want to find out if you qualify for the Paraquat Lawsuit right away? 

Use our chatbot on this page to receive a free instant online case evaluation right now.

The Paraquat Lawsuit is ongoing, and our lawyers are still accepting cases from those affected by exposure to the herbicide.

Paraquat Lawsuits involve claims of Parkinson’s disease and other severe health conditions resulting from exposure to the herbicide.

The core arguments in the Paraquat Herbicide lawsuits revolve around:

• Toxic Exposure: Plaintiffs argue that Paraquat is highly toxic and exposure can lead to severe health issues, including Parkinson’s disease.
• Failure to Warn: Many lawsuits claim that manufacturers failed to provide adequate warnings about the risks associated with Paraquat exposure.
• Negligent Distribution: Allegations include that Paraquat was distributed without sufficient safety measures to protect users from its harmful effects.

Lawmakers and advocates are attempting to regulate Paraquat more strictly due to its health risks, with California leading the charge on a bill to ban Paraquat completely in the state.

Contact TorHoerman Law for a free consultation to discuss your legal options and talk to a Paraquat Lawyer about filing a lawsuit.

Want to find out if you qualify for the Paraquat Lawsuit right away? 

Use our chatbot on this page to receive a free instant online case evaluation right now.

The Paraquat Parkinson’s lawsuit claims that exposure to the herbicide Paraquat is linked to Parkinson’s disease.

This lawsuit seeks to hold manufacturers accountable for the associated health risks.

In June, there were 5,680 Paraquat Parkinson’s lawsuit filings.

By July, this number increased to 5,770, reflecting growing awareness of Paraquat’s dangers.

Paraquat exposure damages neurons that produce dopamine, leading to Parkinson’s disease symptoms like tremors and impaired movement.

These health impacts have prompted more individuals to join the Paraquat Parkinson’s lawsuit.

The Paraquat Parkinson’s lawsuit aims to hold manufacturers responsible.

Affected individuals should consult a Paraquat Parkinson’s lawyer.

Contact TorHoerman Law for a free consultation to discuss your legal options and talk to a Paraquat Lawyer about filing a lawsuit.

Want to find out if you qualify for the Paraquat Lawsuit right away? 

Use our chatbot on this page to receive a free instant online case evaluation right now.

The court conducted hearings on Daubert motions, a critical phase where the validity of expert witness testimonies from both parties was scrutinized.

These motions are pivotal as they determine the admissibility of scientific evidence in the trials.

Regrettably, the court decided to exclude the primary causation expert witness for the plaintiffs.

This decision directly led to the dismissal of four cases that were scheduled for trial.

While this outcome was unforeseen and unfavorable, it is important to note that this ruling impacts only those specific cases.

An appeal is currently being prepared to challenge this ruling.

The court is proactive in progressing the Paraquat cases; additional trials are being scheduled.

Both plaintiffs’ and defendants’ legal teams have been instructed to identify cases that can be moved forward toward trial settings.

As we prepare for upcoming trials, our team is gathering further evidence and working with new experts to bolster the cases.

We continue to collect necessary documents, including medical records, to support each client’s situation comprehensively.

We encourage all our clients to remain engaged and responsive to any requests for information.

Your cooperation is vital for us to advocate effectively on your behalf.

Contact TorHoerman Law for a free consultation to discuss your legal options and talk to a Paraquat Lawyer about filing a lawsuit.

Want to find out if you qualify for the Paraquat Lawsuit right away? 

Use our chatbot on this page to receive a free instant online case evaluation right now.

The Paraquat Lawsuit revolves around the severe health risks allegedly associated with the use of Paraquat, a widely used herbicide known for its high toxicity.

There was a slight increase in Paraquat case filings from 5,590 in may, to 5,680 in june.

Paraquat has been linked to serious health issues, including Parkinson’s disease, due to its high level of toxicity. It is extremely toxic when ingested, and exposure can also cause severe lung damage and other respiratory problems.

Studies have consistently highlighted its acute toxicity and the potential for chronic health effects from prolonged exposure.

Our experienced Paraquat lawyers can provide guidance on how to pursue compensation for medical expenses, lost income, and damages.

Contact TorHoerman Law for a free consultation to discuss your legal options and talk to a Paraquat Lawyer about filing a lawsuit.

Want to find out if you qualify for the Paraquat Lawsuit right away? 

Use our chatbot on this page to receive a free instant online case evaluation right now.

New developments have surfaced in the ongoing lawsuit over the safety of Paraquat, a pesticide linked to severe health risks, including Parkinson’s disease.

The California State Assembly voted to advance Assembly Bill 1963, which aims to ban the use of Paraquat in agricultural settings starting January 1, 2026.

This legislation, if enacted, positions California as the first state to prohibit Paraquat use.

The Environmental Working Group (EWG) supports the bill and over 60 countries have already banned paraquat due to its toxic effects.

EWG’s analysis reveals that paraquat use is heavily concentrated in California’s agricultural counties, predominantly affecting latino communities.

On May 29, the House Agriculture Committee moved forward with a Farm Bill proposal containing provisions that may significantly impact pesticide regulation and litigation in the US.

The bill positions the U.S. Environmental Protection Agency (EPA) as the primary authority on pesticide safety, potentially limiting the ability of states to enact stricter regulations.

This bill is a direct result of lobbying by major agricultural and chemical companies.

These companies, including Bayer and organizations like CropLife America, advocate for federal control over pesticide safety to prevent states from imposing stricter rules.

Their lobbying aims to create a uniform regulatory environment that benefits their business operations, reducing the risk of facing different laws in different states or costly lawsuits related to pesticide harms.

If you or a loved one have suffered from Paraquat exposure and subsequently developed Parkinson’s Disease or other serious health conditions, you may be eligible to file a Paraquat Lawsuit.

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify for a Paraquat Lawsuit instantly.

The popular herbicide, Paraquat, is linked to serious health risks such as Parkinson’s disease.

Paraquat is one of the most widely used weed-killing chemicals in the world.

Farmers use it both to control weeds before planting their crops and to dry out crops for harvest, In the US, the chemical is used in orchards, wheat fields, pastures where livestock graze, cotton fields, and elsewhere.

Manufacturers of Paraquat, such as Syngenta, are accused of failing to warn about the severe risks associated with its use, despite long-standing evidence of its potential to cause neurodegenerative disorders.

Paraquat is claimed to have the ability to induce oxidative stress, damaging critical brain cells responsible for movement.

This damage primarily affects dopamine-producing neurons, leading to Parkinson’s symptoms like tremors and stiffness.

Potential settlements in the Paraquat Lawsuit may range between $20,000 to over $1,000,000 per person depending on individual circumstances and the direction of the litigation as a whole.

If you or a loved one have suffered from Paraquat exposure and subsequently developed Parkinson’s Disease or other serious health conditions, you may be eligible to file a Paraquat Lawsuit.

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify for a Paraquat Lawsuit instantly.

A total of 5,590 Paraquat Lawsuits are pending according to the most recent filings published by the Judicial Panel on Multidistrict Litigation (JPML).

225 new Paraquat Lawsuits were sent to the MDL in the past month.

Plaintiffs claim that Paraquat, a widely used herbicide, is linked to the development of Parkinson’s disease.

Paraquat is used across the world for its effectiveness in controlling weeds and grass that are resistant to other herbicides.

However, its potential neurotoxic effects have resulted in thousands of lawsuits filed against the manufacturer (Syngenta), as plaintiffs claim that the company failed to provide adequate warnings about the risks of Parkinson’s disease.

In California, lawmakers are pushing for a ban on Paraquat due to its “undeniable” danger to public health and the environment.

Lawmakers also argue that Paraquat is causing a Parkinson’s epidemic and that use of the herbicide poses a high potential for injury and death.

If you or a loved one were exposed to Paraquat and developed Parkinson’s disease, you may be eligible to file a Paraquat Lawsuit and seek compensation. 

Contact us today for a free consultation. 

Use the chatbot on this page to find out if you qualify to file a Paraquat Lawsuit instantly.

In a significant development in the Paraquat Products Liability Litigation, U.S. District Judge Nancy J. Rosenstengel dismissed the first set of bellwether cases set for trial, ruling against the plaintiffs’ expert testimony.

The decision came after a detailed review by Judge Rosenstengel, who is presiding over the multidistrict litigation involving claims that Paraquat exposure can lead to Parkinson’s disease.

The dismissed cases, which had completed both fact and expert discovery phases, hinged on the testimony of Cornell University professor Martin Wells.

Judge Rosenstengel excluded his testimony, criticizing it as lacking a credible foundation and not aligning with the scientific consensus, which does not support the claim that Paraquat causes Parkinson’s disease.

This ruling impacts several individual cases of plaintiffs who alleged that their exposure to Paraquat, sold in the U.S. as Gramoxone by Syngenta and previously by Chevron until the 1980s, resulted in their development of the disease.

Despite being banned or restricted in many countries due to its toxicity, paraquat remains widely used in the United States.

The plaintiffs’ lead attorneys, representing over 5,000 cases still pending, expressed their intention to appeal and select new cases for trial.

Lawyers continue to argue that a substantial body of research supports their claims regarding Paraquat’s risks and subsequent health effects.

Both Syngenta and Chevron maintain their position that Paraquat does not cause Parkinson’s disease.

This pivotal ruling not only affects the immediate cases but also sets a critical precedent for the remaining claims in this extensive litigation.

Our law firm is still accepting new clients for the Paraquat Lawsuit. 

Contact us for a free consultation, or use the chatbot on this page to find out if you qualify for the Paraquat Lawsuit instantly.

California is on the verge of enacting a ban on the herbicide Paraquat, a chemical linked to severe health risks, including Parkinson’s disease, childhood leukemia, and respiratory damage.

An epidemiological study of central California found that people living within a third of a mile of where paraquat is sprayed are twice as likely to develop Parkinson’s.

Despite its ban in the EU and over 60 countries, Paraquat remains widely used in the U.S., with California being a major consumer of crops such as almonds, grapes, and pistachios.

An analysis by the Environmental Working Group (EWG) reveals that low-income Latinos in California, where Paraquat is extensively used on croplands, face significant risks from the herbicide, banned in over 60 countries for its dangers but still permitted in the U.S.

Paraquat use is concentrated in five counties with a majority Latino population and high poverty rates.

The legislation, set to eliminate all uses of Paraquat by January 2026.

If you’ve been exposed to Paraquat and subsequently developed Parkinson’s Disease or other related health problems, you may be eligible to file a Paraquat Lawsuit. 

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to find out if you qualify for the Paraquat Lawsuit instantly. 

There are currently 5,365 Paraquat Lawsuits pending in the MDL, according to the most recent JPML filings.

This marks an increase of nearly fifty cases from the 5,318 Paraquat Lawsuits reported on March 1st.

A growing number of individuals are stepping forward to file claims against the manufacturers of Paraquat, motivated by health issues they claim are linked to exposure to the herbicide.

Paraquat is an herbicide used extensively in agriculture for weed and grass control.

Paraquat has been the subject of controversy and legal action due to its potential health risks, including Parkinson’s disease and other serious health conditions.

Individuals filing Paraquat Lawsuits often include agricultural workers, farmers, and others who have been exposed to Paraquat in their line of work, claiming that exposure has led to significant health problems.

If you or a loved one has faced the adverse effects of Paraquat exposure, call TorHoerman Law today for a free consultation. 

You can also use the chatbot on this page to find out if you qualify for the Paraquat Lawsuit. 

241 new cases were added to the Paraquat MDL in the month of February, according to the most recent JPML filings.

On February 1st, the Judicial Panel for Multidistrict Litigation (JPML) reported that there were 5,077 Paraquat Lawsuits pending in the MDL.

On March 1st, the JPML reported 5,318 Paraquat Lawsuits pending in the MDL.

The Paraquat Lawsuit addresses the growing concern about the potential harmful effects of the herbicide, which is linked to Parkinson’s disease.

Paraquat is a toxic chemical that has a lethal dose of only 2.5 grams, and increases risk for kidney failure, heart failure, liver failure, and lung scarring.

Individuals who were exposed to Paraquat and developed Parkinson’s Disease are taking action against manufacturers.

The companies, Syngenta, Chevron, and Growmark, are accused of negligence and breaching their duty to warn consumers about the herbicide’s potential risks and side effects.

If you or someone you know has been diagnosed with Parkinson’s disease after exposure to Paraquat, you may be eligible to participate in the Paraquat Lawsuit.For more information and a free consultation, contact TorHoerman Law. 

You can also use the chatbot on this page for immediate assistance and to find out if you qualify for this lawsuit. 

Chief U.S. District Judge Nancy Rosenstengel has selected nine replacement plaintiffs for the substance of claims linking the weed killer paraquat to Parkinson’s disease after initial dismissals.

The judge expressed concerns about the increasing number of claims without merit and plans to continue replacing plaintiffs who dismiss their claims.

With over 5,000 claims from federal courts in multiple states, Rosenstengel had planned jury trials to facilitate a global settlement, selecting six trial plaintiffs initially for the paraquat weed killer trials.

Issues such as implausible theories of liability and evidentiary concerns led to voluntary dismissals.

Rosenstengel has set a deadline for depositions and third-party discovery, highlighting the need to identify cases lacking a plausible link to paraquat exposure.

Plaintiffs are required to complete limited discovery by April 8th, with special master Randi Ellis overseeing requests for documents or third-party depositions.

A special master, like Randi Ellis, is a court-appointed individual responsible for overseeing specific aspects of the case, such as managing discovery or resolving disputes.

The judge also indicated the expectation for discovery to involve subpoenas to retailers for proof of purchase and affidavits from supervisors regarding plaintiffs’ use of paraquat.

Currently, Rosenstengel has not established a trial schedule as the case progresses.

Contact TorHoerman law for a consultation if you believe exposure to Paraquat has led to your Parkinson’s disease diagnosis. 

Use the chatbot on this page to determine your eligibility for the Paraquat Lawsuit.

On January 31, 2024 the Environmental Protection Agency (EPA) released a 63 page report on the herbicide ingredient Paraquat Dichloride, concluding that the herbicide is safe for use across America, despite an overwhelming amount of research that says otherwise.

The report acknowledges concerns about the link between paraquat and Parkinson’s disease, highlighting the ongoing debate surrounding its safety.

Furthermore, the report establishes that only certified applicators suited in protective clothing are permitted to use paraquat.

In 2021, the agency reauthorized the use of herbicides containing paraquat, leading to a lawsuit from a coalition of agricultural and public health organizations.

They accused the EPA of disregarding widespread scientific agreement that associates the chemical with Parkinson’s disease.

Regardless of the EPA findings, there are still over 5,000 pending personal injury suits filed in this Multi-District Litigation (MDL).

According to the Brain Research journal, exposure to even low levels of paraquat may increase vulnerability of dopamine-producing nerve endings in humans and accelerate nerve cell degeneration.

Moreover, exposure to Paraquat has been associated with the onset of Parkinson’s disease and various other health issues.

Nearly 60 nations have banned the chemical, including political unions such as the EU and the UK.

Contact TorHoerman Law for a free consultation if you’ve developed Parksinon’s disease after being exposed to Paraquat. 

You can also use the chatbot on this page to find out if you qualify for the Paraquat Lawsuit instantly. 

Currently, there are a total of 5,077 filings in the most recent JPML filings.

Multi-District Litigations (MDLs) are legal procedures in the United States designed to handle multiple related civil lawsuits that involve similar issues, facts, or defendants.

When numerous individuals or entities file lawsuits related to a common set of circumstances, such as product liability, pharmaceuticals, or mass tort cases, these cases can be consolidated into a single federal district court for pretrial proceedings.

MDLs aim to streamline the litigation process by centralizing the discovery process, reducing duplication of efforts, and ensuring consistent rulings on key legal issues.

If you or a loved one were exposed to Paraquat and subsequently developed Parkinson’s Disease or another related health problem, you may be eligible to file a Paraquat Lawsuit. 

Contact TorHoerman Law for a free consultation. You can also use the chatbot on this page to find out if you qualify for a Paraquat Lawsuit instantly.

Case Management Order No. 20 (CMO 20), entered on January 22, 2024, orders additional limited discovery for 25 selected plaintiffs to ascertain the plausibility of their claims and streamline the litigation process.

After a motion filed by Defendants and subsequent discussions, the Court decided to focus on identifying and addressing cases with no plausible basis for inclusion in this litigation.

Case Management Order No. 18 (CMO 18), entered on May 15, 2023, expressed worries about cases in the docket that presented unlikely or unrealistic theories of liability, particularly those related to paraquat exposure.

The Court identified four categories of cases that raised such concerns, including cases where plaintiffs had no information about their exposure to paraquat or lacked medical evidence to support a Parkinson’s disease diagnosis.

To address these concerns, the judge decided not to keep cases on the docket that were not legitimate cases.

Consequently, the defendants identified 25 cases with what they deemed implausible claims.

The court ordered limited discovery for these 25 plaintiffs, which includes depositions and third-party discovery, to assess the validity of their claims.

It’s important to note that this pertains to only 25 cases out of a total of 5,000.

The Court established a deadline to complete plaintiffs’ depositions by March 22, 2024, and mandated the parties to provide a joint summary report of each plaintiff’s testimony.

If you or a loved one were exposed to Paraquat and subsequently developed Parkinson’s Disease or another related health problem, you may be eligible to file a Paraquat Lawsuit. 

Contact TorHoerman Law for a free consultation. You can also use the chatbot on this page to find out if you qualify for a Paraquat Lawsuit instantly.

In the past month, the Paraquat MDL has seen a substantial influx of 200 new cases.

This raises the total number of pending cases within the MDL to 4,986.

If you or a loved one were exposed to Paraquat and subsequently developed Parkinson’s Disease or another related health problem, you may be eligible to file a Paraquat Lawsuit. 

Contact TorHoerman Law for a free consultation. You can also use the chatbot on this page to find out if you qualify for a Paraquat Lawsuit instantly.

Judge Nancy Rosenstengel has postponed the upcoming Paraquat bellwether trial, originally set to take place in October, to give more time for her to make decisions on the daubert hearings.

A bellwether trial is essentially a test trial in MDLs that are tried before the rest to determine how other cases will be rewarded, and a daubert hearing is an argument between the plaintiff and defendant, presided over by the judge, to determine if and how expert testimony will be heard in court.

Judge Rosenstengel requested both parties submit supplemental briefs about the daubert hearings and/or issues they found throughout the hearings.

Contact us for a free consultation or use the chatbot on this page to find out if you qualify for the Paraquat Lawsuit instantly.

The Daubert trial on an epidemiologist started on August 20th.

Dr. Martin Wells, who has previously concluded that paraquat plays a significant role in causing Parkinson’s disease, is being vetted by Judge Nancy Rosenstengel to see if his testimony will be allowed in court.

There are 4,554 paraquat lawsuits pending in Illinois federal court as of August 22nd, 2023, and the first bellwether trial has been rescheduled for October 2023.

If you or a loved one were exposed to Paraquat and subsequently developed Parkinson’s Disease or another related health problem, you may be eligible to file a Paraquat Lawsuit. 

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify for a Paraquat Lawsuit instantly.

The Plaintiffs and Defendants are currently submitting Daubert motions, which are motions where one side challenges the validity or credibility of the opposing party’s expert witness.

Each side is attempting to have the other side’s expert witness struck and unable to testify.

Defendants have the opportunity to file Motions to Dismiss, where they can request that certain claims made by the Plaintiffs be dismissed in their entirety.

The court has set the hearings for these for the week of August 21st, 2023.

Chad Finley, appointed by the Court to serve on the Plaintiffs’ Executive Committee, is working with other plaintiffs’ counsel on these motions and responses.

2024 California Bellwether Cases

Additionally, there are currently four (4) cases set for trial in California set to begin in January 2024.

A bellwether trial refers to a trial setting of a representative case selected from the larger group of Paraquat cases.

The purpose of this is to gauge how the court and a jury will respond to the evidence and arguments presented by both parties.

The outcomes of these cases provide guidance for the parties on how to proceed in the overall litigation or affect the resolution of other cases.

The vetting process for the case selection is extensive, with efforts made to select cases that are representative of the filed cases.

The outcome of the bellwether trials will not directly affect cases, but the rulings related to experts and other evidentiary issues will affect the ongoing litigation.

Our attorneys will be required to prove both exposure to paraquat, and how that exposure caused Parkinson’s disease.

Visit this page for more updates on the Paraquat Lawsuit, and reach out to our law firm if you have any questions or concerns.

If you or a loved one were exposed to Paraquat and subsequently developed Parkinson’s Disease or another related health problem, you may be eligible to file a Paraquat Lawsuit. 

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify for a Paraquat Lawsuit instantly.

Paraquat lawyers across the country are filing on behalf of people who’ve suffered from Parkinson’s Disease and other conditions, and their claims are being consolidated in the Paraquat MDL.

Judge Nancy Rosenstengel has ordered plaintiff lawyers in the Paraquat Lawsuit to provide information on how many of their clients are deceased.

The order comes after concerns were raised about the integrity of the docket in the litigation, with defendants Syngenta and Chevron finding active plaintiffs in obituaries online.

The plaintiff lawyers have been given 31 days to certify whether each plaintiff is living or deceased and, if deceased, provide information about the person appointed to act on behalf of the estate.

Cases for which certification cannot be provided may be subject to dismissal.

The order also directs the parties to confer on cases that present implausible theories of proof and suggests identifying cases that may not have viable causes of action.

Visit this page for more updates on the Paraquat Lawsuit, and reach out to our law firm if you have any questions or concerns.

If you or a loved one were exposed to Paraquat and subsequently developed Parkinson’s Disease or another related health problem, you may be eligible to file a Paraquat Lawsuit. 

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify for a Paraquat Lawsuit instantly.

Bellwether trials are scheduled for this summer, and by then we may have a better understanding of potential Paraquat settlement amounts.

Bellwether trials are a small consolidation of lawsuits, taken from a larger group of similar cases, to be tried first.

The bellwether trial is like a practice run to help anticipate the results of future similar cases.

For now, our Paraquat Lawyers estimate that settlement amounts for Paraquat Lawsuits could range between $20,000 to over $1,000,000+.

These estimates are by no means a guarantee of financial compensation for your Paraquat Lawsuit, they are merely estimations based on previous chemical exposure lawsuits and other product liability lawsuits.

Visit this page for more updates on the Paraquat Lawsuit, and reach out to our law firm if you have any questions or concerns.

If you or a loved one were exposed to Paraquat and subsequently developed Parkinson’s Disease or another related health problem, you may be eligible to file a Paraquat Lawsuit. 

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify for a Paraquat Lawsuit instantly.

The Paraquat Lawsuit for Parkinson’s Disease and other chronic exposure related injuries is ongoing.

Paraquat lawyers across the country are filing on behalf of people who’ve suffered, and their claims are being consolidated in the Paraquat MDL.

More than 3,000 cases have been consolidated in the national Paraquat MDL.

In Pennsylvania, there is a state MDL that has over 250 plaintiffs consolidated.

Exposure to Paraquat has been known to increase for Parkinson’s Disease and other serious health conditions for years.

Dating back to the 1960s, Syngenta had knowledge of its health risks and made an effort to conceal these findings from the public.

If you or a loved one were exposed to Paraquat and subsequently developed Parkinson’s Disease or other related health conditions, you may be eligible to file a Paraquat Lawsuit. 

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify for a Paraquat Lawsuit instantly.

The Paraquat Lawsuit for Parkinson’s Disease and other chronic exposure related injuries is ongoing.

Paraquat lawyers across the country are filing on behalf of people who’ve suffered, and their claims are being consolidated in the Paraquat MDL.

As of March 2023, over 3,000 Paraquat Lawsuits filed in the Paraquat MDL, and more are expected to be centralized in the US District Court: Southern District of Illinois.

The first Paraquat Lawsuit trial (bellwether trial) was set for November 2022, but was pushed back by the Paraquat MDL judge due to an influx of new Paraquat lawsuits filed into the MDL.

Our law firm is keeping a close eye on the developments in the Paraquat Lawsuit.

Visit this page for more Paraquat Lawsuit updates as they become available.

The Paraquat Lawsuit is ongoing and lawyers across the country are still accepting clients.

Cases are continually being added to the Paraquat MDL, now totaling over 2,700 cases centralized in the US District Court for the Southern District of Illinois.

If you or a loved one were exposed to Paraquat and subsequently developed Parkinson’s Disease or other health problems, you may be eligible to file a claim.

Contact TorHoerman Law for a free consultation.

You can also use the chatbot on this page to find out if you qualify in under two minutes.

The Paraquat Lawsuit is ongoing and lawyers across the country are still accepting cases.

One of the most recent Paraquat cases was filed by a Kentucky man, claiming that he developed symptoms of Parkinson’s disease from years of spraying the weedkiller Paraquat on his family farm.

The complaint was filed in the U.S. District Court for the Southern District of Illinois and accuses Syngenta Crop Protection and Chevron U.S.A. of failing to provide adequate warnings about the risk of Parkinson’s disease symptoms from using their Paraquat products.

If you were exposed to Paraquat and subsequently developed Parkinson’s Disease, you may be eligible to file a Paraquat Lawsuit.

Contact TorHoerman Law for a free consultation or use the chatbot on this page to see if you qualify for a Paraquat Lawsuit instantly.

The Paraquat litigation is ongoing and lawyers across the country are still accepting new clients and filing claims on their behalf.

Bellwether trials in the Paraquat multidistrict litigation (MDL 3004) are scheduled for July 2023. Hundreds of cases are continually being consolidated in the MDL.

Visit this page for more updates on the Paraquat litigation as they become available.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify for a Paraquat lawsuit instantly.

The Paraquat Lawsuit is ongoing and lawyers across the country are accepting clients from all 50 states.

Paraquat cases are being consolidated in the multidistrict litigation (MDL) every month, now made easier by a master pleading form available on the US District Court: Southern District of Illinois Paraquat MDL website.

Visit this page for more updates as they become available.

The Paraquat Lawsuit is ongoing and lawyers across the country are still accepting cases.

The bellwether trial that was scheduled for November of this year has been pushed back to July 2023.

The order from Chief Judge Rosenstengel also resets some other important dates in the Paraquat MDL for summary judgment motions and Daubert motions and their responses and replies.

The Paraquat litigation is ongoing and lawyers are still accepting clients.

Every month, more cases are consolidated in the Paraquat Multidistrict Litigation (MDL  3004).

The anticipation is building for the November 2022 Bellwether Trials.

Sixteen bellwether trials were selected, eight picked by the plaintiffs and eight picked by the defense.

Visit this page for updates on Paraquat lawsuits and the MDL.

A Supreme Court decision in the Roundup Lawsuit may have big implications on the Paraquat Litigation.

The court’s decision to remove preemption as an argument by the defense may now be applicable to Paraquat Lawsuits.

In an appeal to the court, defense lawyers in the Roundup Litigation used an EPA report, which stated that their product was “not likely to cause cancer”, to argue that thousands of lawsuits should be thrown out.

The Supreme Court rejected this appeal and ordered the EPA to reexamine its findings.

The Paraquat litigation is ongoing and lawyers across the country are still accepting cases.

Chief Judge on the Paraquat MDL, Nancy  J. Rosenstengel, issued a Discovery Schedule  in late May 2022.

This schedule amends deadlines for some of the Bellwether Cases.

Dates for the Bellwether Trials are subject to change, but they may start as early as November 2022.

Upwards of thirty (30) cases were consolidated into multidistrict litigation (MDL) each week in the month of June.

The potential size of the lawsuit may also impact the trial dates for the Bellwether Cases.